2021
DOI: 10.20945/2359-3997000000354
|View full text |Cite
|
Sign up to set email alerts
|

Factors associated to serum paraoxonase 1 activity in patients with cardiovascular disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 43 publications
0
1
0
Order By: Relevance
“…Paraoxonase (PON1) is a key component of HDL and can deactivate toxic products generated from the oxidation of LDL lipid components (Durrington et al, 2023). There is ample evidence supporting the potential protective effect of PON-1 in the atherogenic process (Longo et al, 2021). The aim of this study was to isolate LDL and investigate the fractions obtained from the alcoholic extract of Aqaqia root to assess their impact on oxidation LDL and paraoxonase 1 activity under in vitro conditions.…”
Section: Introductionmentioning
confidence: 99%
“…Paraoxonase (PON1) is a key component of HDL and can deactivate toxic products generated from the oxidation of LDL lipid components (Durrington et al, 2023). There is ample evidence supporting the potential protective effect of PON-1 in the atherogenic process (Longo et al, 2021). The aim of this study was to isolate LDL and investigate the fractions obtained from the alcoholic extract of Aqaqia root to assess their impact on oxidation LDL and paraoxonase 1 activity under in vitro conditions.…”
Section: Introductionmentioning
confidence: 99%